← Back
$KTTA All transactions

Pasithea Therapeutics Corp.

A

$ Value

$0

Shares

317,266

Price

$0

Filed

Oct 27

Insider

Name

Schneiderman Daniel H

Title

Chief Financial Officer

CIK

0001565536

Roles

Officer

Transaction Details

Transaction Date

2025-10-24

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

317,266

Footnotes

The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan).

Filing Info

Accession No.

0001213900-25-102681

Form Type

4

Issuer CIK

0001841330

Schneiderman Daniel H's History

Date Ticker Type Value
2025-11-28 KTTA A $20K
2025-10-24 KTTA A $0

Other Insiders at KTTA (90d)

No other insider activity at this issuer in the last 90 days.